Global Drug Discovery Informatics Market Opportunities and Forecast 2023-2030

Drug Discovery Informatics Market Overview

The global Drug Discovery Informatics market is expected to witness significant growth in the forecast period. Market growth is mainly driven by factors such as the rising R&D expenditure, growing support for research, particularly in the area of rare diseases, and the increasing use of informatics in drug discovery. Additionally, the cost and time of drug discovery are reduced to a very large extent in comparison with the traditional drug discovery process. This crucial fact is remarkably contributing to the growth of the global Drug Discovery Informatics market in the coming years.

Moreover, the drug discovery informatics computer applications are used by the healthcare industry. As well, most of the pharmaceutical and biotechnological companies have employed scientists dedicated to using drug discovery informatics for a decade or more. The drug discovery informatics delivers higher autonomy to more researchers, and also laboratory scientists, and better decision-making tools. All these noteworthy factors are significantly contributing to the growth of the global Drug Discovery Informatics market in the forthcoming years.

On the downside, the scarcity of skilled professionals and the high setup cost of informatics software is projected to hamper the growth of the Drug Discovery Informatics market in the forecast period. Furthermore, the technological progressions in drug discovery informatics that are employed by computational informatics are leading to developments in scientific innovation. This key fact positively impacting towards the growth of the market.

Covid-19 Impact on Drug Discovery Informatics Market:

In addition, the current Drug Discovery Informatics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Drug Discovery Informatics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Drug Discovery Informatics Market Segment Overview

Based on the function, the Sequencing and Target Data Analysis segment accounted for the largest share of the drug discovery informatics market. This can be attributed to increased application for sequencing analysis for the new drug entity and ease of handling of information from different sources and different domains. According to end-user, the Pharmaceutical & Biotechnology Companies segment has significant growth in the market. Pharmaceutical companies are using this informatics software broadly for pre-clinical research & development, target identification, compound screening, and lead identification, and streamlining their drug discovery process.  This key fact largely contributes to the growth of this segment.

Additionally, increasing uses of the drug discovery informatics such as the scientists use it to communicate their ideas with their colleagues in computational chemistry, and biology to design small parallel libraries as well as to conduct a preliminary analysis of interactions between the ligand and receptor are majorly supported to the development to the global drug discovery informatics market.

Drug Discovery Informatics Market, By Product

·       Development Informatics
·       Discovery Informatics

Drug Discovery Informatics Market, By Mode

·       Outsourced Informatics
·       In-House Informatics

Drug Discovery Informatics Market, By Function

·       Sequencing and Target Data Analysis
·       Docking
·       Lead Generation Informatics
·       Identification & Validation Informatics
·       Molecular Modeling
·       Others

Drug Discovery Informatics Market, By End-User

·       Contract Research Organizations
·       Pharmaceutical & Biotechnology Companies
·       Others

Drug Discovery Informatics Market Regional Overview

Region-wise, North America holds the largest share of the market. This is due to the presence of well-established CROs, rising R&D expenditure by pharmaceutical and biopharmaceutical companies, and the increasing technological advancements in drug discovery informatics in this region. Likewise, Asia pacific is expected to grow at a fast growth rate during the forecast period. This can be attributed to the higher adoption of drug discovery informatics in this region. Similarly, the Middle East & Africa, and Latin America are expected to register the fastest growth during the forecast period. This is owing to the rising awareness regarding drug discovery informatics in these regions.

Drug Discovery Informatics Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Drug Discovery Informatics Market, Key Players

·       Charles River Laboratories International, Inc.
·       Thermo Fisher Scientific
·       PerkinElmer Inc.
·       Biogen Inc.
·       Boehringer Ingelheim GmbH
·       Insilico Medicine, Inc.
·       International Business Machines Corporation
·       Schrödinger, LLC
·       Albany Molecular Research Inc. (AMRI)
·       Certara, L.P.